Minerva Biotechnology and Biomolecular Research
Scope & Guideline
Pioneering Insights in Biomolecular Research for a Sustainable Future
Introduction
Aims and Scopes
- Biotechnology Applications in Health Sciences:
The journal explores various applications of biotechnology, particularly in health sciences, focusing on the development of novel therapeutic strategies and diagnostic tools. - Molecular Mechanisms of Disease:
Research published in the journal investigates the molecular and genetic underpinnings of diseases, aiming to elucidate pathways and mechanisms that could be targeted for treatment. - Innovative Therapeutics and Drug Development:
A core area of focus includes the discovery and development of new drugs, including the use of natural products, nanoparticles, and biopharmaceuticals in therapeutic contexts. - Cancer Research and Therapeutics:
The journal consistently emphasizes cancer research, exploring genetic, biochemical, and immunological aspects to improve treatment outcomes and patient care. - In-silico and Computational Studies:
There is a significant focus on in-silico approaches for drug discovery and biomarker identification, reflecting the growing importance of computational methods in biological research. - Environmental and Plant Biotechnology:
Research on the environmental applications of biotechnology, including the green synthesis of nanoparticles and the use of plant-derived compounds for health benefits, is also a notable area of interest.
Trending and Emerging
- Precision Medicine and Genomics:
An increasing focus on precision medicine, especially regarding genetic testing and tailored therapies, is evident, showcasing the journal's commitment to advancing personalized healthcare. - Immunotherapy and Cancer Treatment:
Emerging themes in immunotherapy, especially in the context of cancer treatment, indicate a growing interest in harnessing the immune system for therapeutic benefits. - Sustainable and Green Biotechnology:
There is a notable trend towards sustainable practices in biotechnology, including the green synthesis of nanoparticles and the use of plant-based compounds, reflecting a broader environmental consciousness. - CRISPR and Gene Editing Technologies:
The rise of CRISPR and other gene editing technologies as a research focus indicates the journal's alignment with cutting-edge advancements in molecular biology. - Microbiome Research:
Research exploring the human microbiome and its implications for health and disease is gaining traction, suggesting an increasing interest in the interplay between microbiota and human health. - COVID-19 Related Research:
Given the global pandemic, there has been a surge in research related to COVID-19, including vaccine development and the understanding of viral mechanisms, which continues to dominate recent publications.
Declining or Waning
- Traditional Pharmacology:
There seems to be a waning interest in traditional pharmacological studies, potentially due to the shift towards more innovative and targeted therapeutic approaches. - Basic Research Without Clinical Implications:
There is a noticeable decline in studies that focus solely on basic biological research without clear implications for clinical practice, as the journal increasingly emphasizes translational research. - General Studies on Infectious Diseases:
While infectious diseases remain a relevant topic, studies that do not provide novel insights into treatment or prevention strategies may be receiving less attention. - Animal Models in Drug Testing:
Research utilizing animal models for drug testing appears to be less frequent, possibly due to ethical concerns and a growing preference for alternative methods, including in-vitro and in-silico studies.
Similar Journals
Chemical Biology Letters
Bridging Theory and Practice in BiochemistryChemical Biology Letters is a prominent academic journal dedicated to the evolving field of biochemistry and its applications in medical and clinical contexts. Published by ScienceIn Publications, this journal serves as a vital platform for researchers, professionals, and students alike, showcasing cutting-edge findings and innovations that drive forward our understanding of chemical interactions in biological systems. With its scope ranging from molecular biology to clinical biochemistry, Chemical Biology Letters is committed to advancing knowledge and fostering collaboration within the scientific community. Recognized for its quality, the journal is categorized in Q4 for Biochemistry and Molecular Biology fields, while achieving notably higher ranks in Medical Biochemistry, reflecting its significant contributions to the discipline. Aiming to remain accessible to a diverse audience, the journal is published in open access format, inviting researchers worldwide to explore and share invaluable insights. Established in 2014, it continues to grow in impact and relevance, paving the way for advancements in both theoretical and applied research within the realm of chemical biology.
Frontiers in Bioscience-Landmark
Shaping the Future of Bioscience ScholarshipFrontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.
Biomedical and Biotechnology Research Journal
Advancing biomedical frontiers through open access innovation.Biomedical and Biotechnology Research Journal is a pioneering, peer-reviewed Open Access platform dedicated to the advancement of knowledge in the fields of biomedical science and biotechnology. Published by WOLTERS KLUWER MEDKNOW PUBLICATIONS since 2017, this journal offers a vital resource for researchers, professionals, and students alike, encompassing a wide range of topics from molecular biology to innovative biotechnological applications. With an impact factor reflecting its commitment to quality research, it proudly ranks in the Q3 category for Biotechnology in 2023 and holds significant positions in Scopus ranks, emphasizing its relevance in the medical and biochemistry sectors. The journal is based in India, and with its open access model, it ensures that cutting-edge research is readily available to a global audience, fostering collaboration and innovation in the rapidly evolving world of biomedicine.
Molecular Biology Research Communications
Cultivating collaboration in the evolving landscape of molecular research.Molecular Biology Research Communications is a distinguished academic journal published by Shiraz University, focusing on the critical and rapidly evolving fields of biochemistry and molecular biology. With an ISSN of 2322-181X and an E-ISSN of 2345-2005, this journal serves as an essential platform for researchers, professionals, and students to disseminate significant findings that contribute to the advancement of knowledge in these disciplines. The journal, operating from Shiraz, Iran, is notable for its contributions from both local and international scholars, offering invaluable insights and fostering scientific collaboration. Although currently indexed in the Q4 quartile across its categories, the journal aims to enhance its impact and visibility in the field as it converges years of research from 2017 to 2024. While the open access option is not available, the journal's commitment to high-quality peer-reviewed research provides a respected avenue for publication.
Computational and Structural Biotechnology Journal
Innovating at the Nexus of Computer Science and Molecular BiologyComputational and Structural Biotechnology Journal is a premier open-access journal published by Elsevier, focusing on the intersection of computer science and molecular biology. Since its inception in 2012, the journal has established itself as a leading platform for innovative research, featuring groundbreaking studies in biochemistry, biophysics, biotechnology, and genetics. With a remarkable Q1 ranking in multiple categories, including Biochemistry and Genetics, it stands out for its high impact, evidenced by its strong Scopus ranking percentile scores. As a vital resource for researchers, professionals, and students, the journal aims to foster the dissemination of essential findings that leverage computational techniques to explore complex biological systems. In a rapidly evolving scientific landscape, Computational and Structural Biotechnology Journal serves as an indispensable resource for those looking to contribute and stay abreast of major advancements in the field.
International Journal of Biological Sciences
Exploring the Depths of Biological KnowledgeInternational Journal of Biological Sciences (ISSN: 1449-2288, E-ISSN: 1449-2288) is a premier open-access journal published by IVYSPRING INTERNATIONAL PUBLISHING since 2005, located in Australia. With a commitment to advancing knowledge in the life sciences, this journal covers a wide spectrum of disciplines, including Applied Microbiology and Biotechnology, Cell Biology, Developmental Biology, Ecology, Evolution, Behavior and Systematics, and Molecular Biology, earning a distinguished Q1 ranking in these fields as of 2023. It stands out with exceptional Scopus rankings, placing in the top ranks across multiple categories, such as the 98th percentile in Ecology, Evolution, Behavior and Systematics and the 94th percentile in Applied Microbiology and Biotechnology. The journal fosters an open access philosophy, ensuring that research findings are readily available to the scientific community and the public, and invites original research articles, reviews, and commentaries. With its mission to disseminate high-quality research, the International Journal of Biological Sciences serves as an essential resource for researchers, professionals, and students seeking to deepen their understanding and drive innovation in biological sciences.
MOLECULAR BIOTECHNOLOGY
Transforming Ideas into Molecular SolutionsMOLECULAR BIOTECHNOLOGY, published by SPRINGERNATURE, is a pivotal journal in the fields of applied microbiology, molecular biology, biochemistry, and biotechnology. Since its inception in 1994, the journal has aimed to disseminate high-quality research that explores the intersection of molecular biology and technology, fostering advancements in biotechnology applications. With an ISSN of 1073-6085 and an E-ISSN of 1559-0305, it has established itself as a significant contributor to the scientific community, currently holding a Q3 ranking across multiple categories including Applied Microbiology & Biotechnology and Biochemistry in the 2023 metrics. Although not an open access publication, the journal remains accessible through various institutional subscriptions, providing valuable insights and findings to researchers and professionals. Given its ongoing commitment to quality and relevance, MOLECULAR BIOTECHNOLOGY serves as an essential resource for those involved in cutting-edge research and innovation in molecular biotechnology and related disciplines.
BIOTECHNOLOGY LETTERS
Innovating Solutions for Tomorrow's ChallengesBIOTECHNOLOGY LETTERS is a prestigious peer-reviewed journal that has been at the forefront of biotechnology research since its inception in 1979. Published by Springer, this esteemed journal serves as a vital platform for disseminating cutting-edge research in the fields of applied microbiology, bioengineering, and biotechnology, with a focus on innovative methodologies and technologies. With an impact factor reflecting its critical contribution to the discipline, BIOTECHNOLOGY LETTERS resides in the Q2 and Q3 tiers of various scientific categories, placing it among the notable journals in the biotechnological landscape. Although it offers traditional access options and does not feature open access, the journal embraces a global readership, encouraging submissions from researchers, professionals, and students eager to explore the dynamic advancements in biotechnology. Situated in the Netherlands, it continues to shape the future of the field through relevant, impactful research that addresses contemporary challenges and opportunities in medicine and beyond.
FASEB JOURNAL
Connecting Researchers to Transformative DiscoveriesFASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.
AIMS Molecular Science
Unlocking Innovations in Molecular ScienceAIMS Molecular Science is a premier open-access journal published by the American Institute of Mathematical Sciences (AIMS), dedicated to the advancement and dissemination of high-quality research in the field of molecular science. Since its inception in 2014, this journal has established itself as a vital platform for researchers and professionals aiming to share their findings in molecular biology, chemistry, and interdisciplinary studies related to these domains. With an increasing focus on the accessibility of scientific knowledge, AIMS Molecular Science supports the open-access movement, ensuring that all published articles are freely available to the global research community. The journal emphasizes originality and significance in research, promoting innovative scientific methodologies and applications. By fostering collaboration and dialogue among scientists, AIMS Molecular Science plays a crucial role in advancing understanding and stimulating progress in molecular sciences.